- A Prospective, Multi-Center, Randomized, Controlled Clinical Trial to Explore the Role of Mesenchymal Stem Cells in Preventing Graft Versus Host DiseaseYao, Han; Wang, Xiaoqi; Huang, Ruihao; Fu, Haixia; Lin, Ren; Feng, Yimei; Deng, Xiaojuan; Chen, Ting; Zhu, Lidan; Liu, Jia; Liu, Yuqing; Zhao, Lu; Wang, Lu; Zhang, Cheng; Kong, Peiyan; Gao, Li; Gao, Lei; Liu, Qifa; Zhang, Xiaohui; Zhang, Xi65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
- Basiliximab in the Prevention of aGVHD for Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Thalassemia Major: A Prospective, Multicenter, Open-Label, Randomized Controlled StudyLiu, Rongrong; Wu, Meiqing; Li, Qiaochuan; Liu, Lianjin; Qin, Chunjie; Chen, Hong; Shi, Lingling; Yang, Gaohui; Shi, Zeyan; Li, Zhongqing; Wei, Zhenbin; Liu, Beicai; Fan, Jing; Chen, Yinghua; Zhou, Xuemei; Zhang, Zhongming; Lai, Yongrong; Liu, Qifa64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), New Orleans, LA, 2022-12-10 To 2022-12-13.
- Haploidentical Stem Cell Transplantation Had a Lower Incidence of Bronchiolitis Obliterans Syndrome Compared with HLA-Matched Sibling Transplantation for Patients with Hematologic Malignancies: Benefit from ATG?Weng, Guangyang; Fan, Zhiping; Huang, Fen; Xu, Na; Jin, Hua; Yu, Sijian; Xuan, Li; Liu, Qifa64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), New Orleans, LA, 2022-12-10 To 2022-12-13.
会议论文
Efficacy and Safety of MSCs Plus Basiliximab for the Treatment of Steroid-Resistant aGVHD after Haploidentical Stem Cell Transplantation: A Multicenter, Randomized, Open-Label Trial
11阅读
